Wellington Management Group LLP bought a new position in Transcat, Inc. (NASDAQ:TRNS – Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 317,015 shares of the scientific and technical instruments company’s stock, valued at approximately $29,409,000. Wellington Management Group LLP owned about 3.39% of Transcat at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Deutsche Bank AG increased its holdings in Transcat by 4.6% during the 4th quarter. Deutsche Bank AG now owns 7,053 shares of the scientific and technical instruments company’s stock worth $400,000 after purchasing an additional 312 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Transcat by 6.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after purchasing an additional 325 shares in the last quarter. Swiss National Bank lifted its holdings in shares of Transcat by 2.2% in the fourth quarter. Swiss National Bank now owns 18,315 shares of the scientific and technical instruments company’s stock valued at $1,039,000 after purchasing an additional 400 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Transcat by 8.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,265 shares of the scientific and technical instruments company’s stock valued at $299,000 after buying an additional 432 shares during the last quarter. Finally, Diversified Trust Co boosted its position in shares of Transcat by 8.8% during the first quarter. Diversified Trust Co now owns 5,495 shares of the scientific and technical instruments company’s stock valued at $404,000 after buying an additional 444 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.
Insider Activity
In related news, Director Craig D. Cairns acquired 1,050 shares of the stock in a transaction on Thursday, August 6th. The shares were acquired at an average price of $93.97 per share, with a total value of $98,668.50. Following the completion of the transaction, the director owned 1,480 shares in the company, valued at approximately $139,075.60. The trade was a 244.19% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Christopher Gillette sold 504 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $94.23, for a total transaction of $47,491.92. Following the completion of the transaction, the director owned 200 shares in the company, valued at approximately $18,846. The trade was a 71.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by corporate insiders.
Transcat Stock Performance
Transcat (NASDAQ:TRNS – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The firm had revenue of $92.95 million during the quarter, compared to the consensus estimate of $86.55 million. As a group, analysts anticipate that Transcat, Inc. will post 1.74 EPS for the current year.
Analyst Ratings Changes
A number of research firms recently commented on TRNS. Northland Securities lowered Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price target for the company. in a research report on Wednesday, August 5th. Zacks Research raised shares of Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Transcat in a research note on Tuesday, August 25th. Finally, Wall Street Zen upgraded shares of Transcat from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $95.00.
Read Our Latest Stock Analysis on Transcat
Transcat Company Profile
Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.
In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.
Read More
- Five stocks we like better than Transcat
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
